Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies
Authors
Keywords
-
Journal
MELANOMA RESEARCH
Volume 33, Issue 6, Pages 462-474
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-10-04
DOI
10.1097/cmr.0000000000000926
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acetylation-dependent regulation of BRAF oncogenic function
- (2022) Xiangpeng Dai et al. Cell Reports
- Resistance Mechanisms to Anti-PD Cancer Immunotherapy
- (2022) Matthew D. Vesely et al. Annual Review of Immunology
- Epigenetics Regulates Antitumor Immunity in Melanoma
- (2022) Yuhan Chen et al. Frontiers in Immunology
- Pathology of Immunotherapy-induced Responses in Cutaneous Melanoma: Current Evidences and Future Perspectives
- (2022) Alice Indini et al. ADVANCES IN ANATOMIC PATHOLOGY
- Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach
- (2021) Kevin B. Kim et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Epigenetic Regulation in Melanoma: Facts and Hopes
- (2021) Emilio Francesco Giunta et al. Cells
- KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements
- (2021) Shang-Min Zhang et al. NATURE
- Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma
- (2021) Chun Yang et al. Cancers
- miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma
- (2021) Mai-Huong Thi Nguyen et al. Biomolecules
- The miRNAs Role in Melanoma and in Its Resistance to Therapy
- (2020) Francesca Varrone et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy
- (2020) Jing Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Gain-of-function genetic alterations of G9a drive oncogenesis
- (2020) Shinichiro Kato et al. Cancer Discovery
- Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma
- (2020) Minjeong Yeon et al. Frontiers in Cell and Developmental Biology
- MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas
- (2019) Ophélia Maertens et al. Cancer Discovery
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target
- (2019) Elias Orouji et al. INTERNATIONAL JOURNAL OF CANCER
- miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
- (2019) Simona Caporali et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial
- (2019) Anna Maria Di Giacomo et al. CLINICAL CANCER RESEARCH
- miR‐140‐5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β‐catenin and NF‐κB cascades
- (2019) Ge Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells
- (2019) Corrado Caslini et al. ONCOGENE
- SOX4: The unappreciated oncogene
- (2019) Carlos S. Moreno SEMINARS IN CANCER BIOLOGY
- 1370PPhase Ib/II study (SENSITIZE) assessing safety, pharmacokinetics (PK), pharmacodynamics (PD), and clinical outcome of domatinostat in combination with pembrolizumab in patients with advanced melanoma refractory/non-responding to prior checkpoint inhibitor therapy
- (2019) J C Hassel et al. ANNALS OF ONCOLOGY
- Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis
- (2019) Wenkang Luan et al. Cell Death & Disease
- Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)
- (2019) Anne Catherine Bretz et al. Journal for ImmunoTherapy of Cancer
- Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression
- (2019) Francesco Mannavola et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation
- (2018) Daniel Zingg et al. CANCER CELL
- An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
- (2018) Liqin Wang et al. CELL
- Long non-coding RNAs in melanoma
- (2018) Xin Yu et al. CELL PROLIFERATION
- Anti-miRNA oligonucleotides: A comprehensive guide for design
- (2018) Joana Filipa Lima et al. RNA Biology
- Epigenetic regulators of programmed death-ligand 1 expression in human cancers
- (2018) Sachin Kumar et al. Translational Research
- Tackling malignant melanoma epigenetically: histone lysine methylation
- (2018) Elias Orouji et al. Clinical Epigenetics
- DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients
- (2017) Mario Venza et al. HUMAN PATHOLOGY
- Epigenetics of malignant melanoma
- (2017) Bruce Moran et al. SEMINARS IN CANCER BIOLOGY
- Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study
- (2017) Yousef Zakharia et al. Oncotarget
- Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression
- (2017) Petko Fiziev et al. Cell Reports
- The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
- (2017) Daniel Zingg et al. Cell Reports
- Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
- (2017) Goran Micevic et al. Clinical Epigenetics
- Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca2+ Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK
- (2017) Luca Hegedüs et al. Frontiers in Oncology
- MITF and BRN2 contribute to metastatic growth after dissemination of melanoma
- (2017) Jacinta L. Simmons et al. Scientific Reports
- Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic
- (2017) Samer Bayda et al. CURRENT MEDICINAL CHEMISTRY
- Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance
- (2016) A. Krumm et al. CANCER RESEARCH
- Inhibition of histone deacetylases in melanoma-a perspective from bench to bedside
- (2016) Eva Hornig et al. EXPERIMENTAL DERMATOLOGY
- TET2 regulates LncRNA-ANRIL expression and inhibits the growth of human gastric cancer cells
- (2016) Wei Deng et al. IUBMB LIFE
- Exploiting Nanotechnology for the Development of MicroRNA-Based Cancer Therapeutics
- (2016) Nikhil Tyagi et al. Journal of Biomedical Nanotechnology
- Melanoma addiction to the long non-coding RNA SAMMSON
- (2016) Eleonora Leucci et al. NATURE
- Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
- (2016) K. E. Pauken et al. SCIENCE
- A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma
- (2016) Nageatte Ibrahim et al. Cancer Medicine
- Panobinostat in multiple myeloma
- (2016) Morie A Gertz Lancet Haematology
- Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer
- (2016) Yuanhui Jia et al. Cell Discovery
- BRAF activated non-coding RNA (BANCR) promoting gastric cancer cells proliferation via regulation of NF-κB1
- (2015) Zhi-Xin Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer
- (2015) Ling Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Epigenetic regulation in human melanoma: past and future
- (2015) Debina Sarkar et al. Epigenetics
- Let-7b overexpression leads to increased radiosensitivity of uveal melanoma cells
- (2015) Yixiong Zhou et al. MELANOMA RESEARCH
- Quantitative Histone Mass Spectrometry Identifies Elevated Histone H3 Lysine 27 (Lys27) Trimethylation in Melanoma
- (2015) Deepanwita Sengupta et al. MOLECULAR & CELLULAR PROTEOMICS
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2
- (2015) G M De Donatis et al. ONCOGENE
- Circulating epigenetic biomarkers in melanoma
- (2015) Yu Xin et al. TUMOR BIOLOGY
- Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
- (2015) Annelien Verfaillie et al. Nature Communications
- Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
- (2015) Elisabetta Vergani et al. Oncotarget
- A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients
- (2015) Shigeshi Ono et al. Oncotarget
- Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma
- (2015) Phil F Cheng et al. GENOME BIOLOGY
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- SWI/SNF Chromatin Remodeling Enzymes in Melanocyte Differentiation and Melanoma
- (2014) A. Mehrotra et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma
- (2014) Rainer Tuominen et al. INTERNATIONAL JOURNAL OF CANCER
- DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations
- (2014) D. M. Marzese et al. NEURO-ONCOLOGY
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study
- (2013) Eyal Greenberg et al. BIOMARKERS
- Long Non-Coding RNA in Cancer
- (2013) Nina Hauptman et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Methylated Tissue Factor Pathway Inhibitor 2 (TFPI2) DNA in Serum Is a Biomarker of Metastatic Melanoma
- (2013) Cristiana Lo Nigro et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MALAT1 — a paradigm for long noncoding RNA function in cancer
- (2013) Tony Gutschner et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- Sensitive detection of melanoma metastasis using circulating microRNA expression profiles
- (2013) Rie Shiiyama et al. MELANOMA RESEARCH
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
- (2013) Cigall Kadoch et al. NATURE GENETICS
- miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma
- (2013) Paige E. Bennett et al. PHYSIOLOGICAL GENOMICS
- BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene
- (2013) Srinivas V. Saladi et al. Pigment Cell & Melanoma Research
- PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma
- (2013) Yan Ye et al. Nature Communications
- PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer
- (2013) Teruyuki Sato et al. Scientific Reports
- Key clinical observations after 5-azacytidine and decitabine treatment of myelodysplastic syndromes suggest practical solutions for better outcomes
- (2013) Y. Saunthararajah Hematology-American Society of Hematology Education Program
- Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
- (2012) Y Xu et al. BRITISH JOURNAL OF CANCER
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
- (2012) Christine Guo Lian et al. CELL
- The BRAFV600E causes widespread alterations in gene methylation in the genome of melanoma cells
- (2012) Peng Hou et al. CELL CYCLE
- BRAFV600Eremodels the melanocyte transcriptome and inducesBANCRto regulate melanoma cell migration
- (2012) Ross J. Flockhart et al. GENOME RESEARCH
- Formulation Approaches to Short Interfering RNA and MicroRNA: Challenges and Implications
- (2012) Diana Guzman-Villanueva et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients
- (2012) Luca Sigalotti et al. Journal of Translational Medicine
- In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA
- (2012) Jason A Hanna et al. LABORATORY INVESTIGATION
- JARID1B expression in human melanoma and benign melanocytic skin lesions
- (2012) Łukasz Kuźbicki et al. MELANOMA RESEARCH
- Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
- (2011) A. Heinemann et al. CANCER RESEARCH
- The Melanoma-Upregulated Long Noncoding RNA SPRY4-IT1 Modulates Apoptosis and Invasion
- (2011) D. Khaitan et al. CANCER RESEARCH
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination
- (2011) Michael Millward et al. INVESTIGATIONAL NEW DRUGS
- miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein
- (2011) Altaf A. Dar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker
- (2011) Hisashi Kanemaru et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy
- (2011) M Gupta et al. LEUKEMIA
- The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
- (2011) Craig J. Ceol et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells
- (2011) Luca A. Petruccelli et al. PLoS One
- The “SWOT” of BRAF Inhibition in Melanoma: RAF Inhibitors, MEK Inhibitors or Both?
- (2011) Moriah H. Nissan et al. Current Oncology Reports
- The Promise of MicroRNA Replacement Therapy
- (2010) A. G. Bader et al. CANCER RESEARCH
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
- (2010) Dmitri Lodygin et al. CELL CYCLE
- Let-7b-mediated suppression of basigin expression and metastasis in mouse melanoma cells
- (2010) Tzu-Yen Fu et al. EXPERIMENTAL CELL RESEARCH
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
- (2010) Rajnish A. Gupta et al. NATURE
- Silencing and re-expression of retinoic acid receptor beta2 in human melanoma
- (2010) Jun Fan et al. Pigment Cell & Melanoma Research
- Epidemiology of invasive cutaneous melanoma
- (2009) R. M. MacKie et al. ANNALS OF ONCOLOGY
- Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial
- (2009) A. I. Daud et al. CLINICAL CANCER RESEARCH
- MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth
- (2008) Julia Schultz et al. CELL RESEARCH
- Frequent p16-Independent Inactivation of p14ARF in Human Melanoma
- (2008) Daniel E. Freedberg et al. JNCI-Journal of the National Cancer Institute
- The Double Bromodomain Proteins Brd2 and Brd3 Couple Histone Acetylation to Transcription
- (2008) Gary LeRoy et al. MOLECULAR CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More